UnknownPhase 2NCT00440349
Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis
Studying IgG4-related retroperitoneal fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Parma
- Principal Investigator
- Carlo Buzio, MDUniversity of Parma
- Intervention
- Tamoxifen(drug)
- Enrollment
- 38 target
- Eligibility
- All sexes
- Timeline
- 2000 – 2007
Study locations (1)
- Department of Clinical Medicine Nephrology and Health Science, Parma University Hospital, Parma, Parma, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00440349 on ClinicalTrials.govOther trials for IgG4-related retroperitoneal fibrosis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT06741423Distinguishing Retroperitoneal Fibrosis and Sarcoma from Other Retroperitoneal Diseases Via RadiomicsHeidelberg University
- RECRUITINGPHASE4NCT05428826Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal FibrosisAssistance Publique - Hôpitaux de Paris
- RECRUITINGNCT04314323National Registry of IRPF in ChinaPeking Union Medical College Hospital
- RECRUITINGNCT04312854A Prospective Cohort Study of IRPF in ChinaPeking Union Medical College Hospital
- RECRUITINGPHASE2, PHASE3NCT04047576Study of Sirolimus in Idiopathic Retroperitoneal FibrosisPeking University International Hospital